Effects of Whole-Body Vibration in Patients with Knee Osteoarthritis.
Acute Effects of Whole-Body Vibration on Pain, Neuromuscular Performance and Gait Quality in Patients with Knee Osteoarthritis. a Randomized Controlled Trial.
1 other identifier
interventional
20
1 country
1
Brief Summary
Knee osteoarthritis is a chronic joint disease with an impact on quality of life and an increasing incidence what leads to huge costs and burden on the economy. The present study investigates immediate effects of whole-body vibration on pain, neuromuscular performance, and gait quality in patients with knee osteoarthritis. Eligible patients (n=20) with knee osteoarthritis grade 2 or 3 on Kallgren Lawrence will complete a 5 minute WBV training and a control condition in a randomized order (cross over design). Pain, maximum strength of the leg flexors and extensors, the chair rise test and gait parameters will be measured directly before and after the intervention/control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2024
CompletedFirst Submitted
Initial submission to the registry
October 18, 2024
CompletedFirst Posted
Study publicly available on registry
October 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 16, 2025
CompletedFebruary 3, 2025
January 1, 2025
6 months
October 18, 2024
January 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in pain of the osteo-arthrotic knee
Changes in pain of the osteo-arthrotic knee during the treadmill test as determined on a visual analogue scale (VAS 0-10).
Changes in pain of the osteoarthrotic knee during the treadmill test as determined on a visual analogue scale (VAS 0-10) before and after 5 min of intervention
Secondary Outcomes (12)
Changes in isometric maximum leg flexion strength of the osteoarthritis knee
Changes in isometric maximum leg flexion strength of the osteoarthritis knee before and after 5 min of Intervention.
Changes in isometric maximum leg extension strength of the osteoarthritis knee
Changes in isometric maximum leg extension strength of the osteoarthritis knee before and after 5 min of Intervention
Changes of number of repetitions in the 30 s sit to stand (chair rise) test
Changes in number of repetitions in the 30 s sit-to-stand test before and after 5 min of intervention
Changes of ipsilateral stride length
Changes of ipsilateral stride length (cm) at treadmill as determined by the 4D motion high-performance lab ( (Firma Diers Formetric, Germany) before and after 5 min of Intervention
Changes of ipsilateral stride time
Changes of ipsilateral stride length (cm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention.
- +7 more secondary outcomes
Study Arms (2)
Whole-Body Vibration
EXPERIMENTALThe intervention (IC) will be specified as a five-minute Whole-Body Vibration session.
Control Condition
OTHERThe control condition (CC) will conduct the same protocol as the intervention condition. The only difference will be that the vibration plate will be switched off.
Interventions
The intervention (IC) will be specified as a five-minute Whole-Body Vibration session. The WBV take place on a side alternating vibration plate (Wellengang, Germany). The patients stand barefoot on the vibration plate on a prescribed position. In this position the amplitude will be 6-7mm. The WBV protocol contains mobilizing sequences with lower frequencies and activating sequences with higher frequencies
Eligibility Criteria
You may qualify if:
- x-ray confirmed knee osteoarthritis (Kallgren-Lawrence 2-3)
- knee pain (NRS 0-10 \>2) for 3 months and at least 50% of the last 30 days
You may not qualify if:
- contraindications for WBV (acute injuries of the musculoskeletal system, new joint endoprosthesis, pregnancy, acute thrombosis, Epilepsia, cholecystolithiasis, nephrolithiasis, heart pace maker),
- other pathologies affecting gait or neuromuscular performance (rheumatic
- opioid medications, cortisol medications and intraarticular injections in the knee during the ist 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oniversity Hospital Erlangen
Erlangen, Bavaria, 91054, Germany
Related Publications (1)
von Stengel S, Kemmler W, Engelke K, Kalender WA. Effect of whole-body vibration on neuromuscular performance and body composition for females 65 years and older: a randomized-controlled trial. Scand J Med Sci Sports. 2012 Feb;22(1):119-27. doi: 10.1111/j.1600-0838.2010.01126.x. Epub 2010 May 24.
PMID: 20500555BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marcel Betsch, MD
University Hospital Erlangen, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessor were unaware of participants status and were not allowed to ask correpondingly
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Research
Study Record Dates
First Submitted
October 18, 2024
First Posted
October 29, 2024
Study Start
July 15, 2024
Primary Completion
January 15, 2025
Study Completion
January 16, 2025
Last Updated
February 3, 2025
Record last verified: 2025-01